New Non-Hormonal Drug Shows Promise for Menopausal Hot Flashes

Elinzanetant significantly reduces symptoms and improves quality of life in Phase III trials.

Elinzanetant, a non-hormonal drug, effectively reduces hot flashes and night sweats.
The drug showed a 50% reduction in symptoms for over 80% of participants in trials.
Participants also reported improved sleep and overall quality of life.
Common side effects included mild headaches and fatigue, with no severe adverse events.
Bayer plans to seek regulatory approval for elinzanetant based on these promising results.